US6103521A
(en)
*
|
1995-02-06 |
2000-08-15 |
Cell Genesys, Inc. |
Multispecific chimeric receptors
|
US5891680A
(en)
*
|
1995-02-08 |
1999-04-06 |
Whitehead Institute For Biomedical Research |
Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
AU6873396A
(en)
*
|
1995-10-16 |
1997-05-07 |
Unilever N.V. |
A bifunctional or bivalent antibody fragment analogue
|
CA2213512A1
(en)
*
|
1995-12-22 |
1997-07-03 |
Toray Industries, Inc. |
Method for producing bioactive fusion protein
|
JP2000508892A
(ja)
|
1996-04-04 |
2000-07-18 |
ユニリーバー・ナームローゼ・ベンノートシャープ |
多価および多特異的抗原結合タンパク
|
US6136311A
(en)
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
US5922845A
(en)
|
1996-07-11 |
1999-07-13 |
Medarex, Inc. |
Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
|
US6165476A
(en)
*
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
US6187564B1
(en)
|
1997-07-10 |
2001-02-13 |
Beth Israel Deaconess Medical Center |
DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics
|
US6242570B1
(en)
|
1997-07-10 |
2001-06-05 |
Beth Israel Deaconess Medical Center |
Production and use of recombinant protein multimers with increased biological activity
|
DK1027439T3
(da)
|
1997-10-27 |
2010-05-10 |
Bac Ip Bv |
Multivalente antigenbindende proteiner
|
DE19819846B4
(de)
*
|
1998-05-05 |
2016-11-24 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Multivalente Antikörper-Konstrukte
|
US6962702B2
(en)
|
1998-06-22 |
2005-11-08 |
Immunomedics Inc. |
Production and use of novel peptide-based agents for use with bi-specific antibodies
|
US7696325B2
(en)
|
1999-03-10 |
2010-04-13 |
Chugai Seiyaku Kabushiki Kaisha |
Polypeptide inducing apoptosis
|
ATE456575T1
(de)
|
1999-10-18 |
2010-02-15 |
Prince Henrys Inst Med Res |
Immun-interaktive fragmente der alpha-c- untereinheit von inhibin
|
DE19957470A1
(de)
|
1999-11-24 |
2001-06-21 |
Actinodrug Pharmaceuticals Gmb |
Tetrahydropyrimidin-Dioxygenase-Gen sowie Verfahren zur enzymatischen in vivo und in vitro Produktion von hydroxylierten Tetrahydropyrimidinen
|
JP2003531588A
(ja)
|
2000-04-11 |
2003-10-28 |
ジェネンテック・インコーポレーテッド |
多価抗体とその用途
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
KR100388942B1
(ko)
*
|
2000-07-08 |
2003-06-25 |
한화석유화학 주식회사 |
인체의 피질 흉선 세포 및 백혈병 종양 세포 표면단백질을 인식하는 분절 항체
|
JPWO2002033072A1
(ja)
|
2000-10-20 |
2004-02-26 |
中外製薬株式会社 |
低分子化tpoアゴニスト抗体
|
CN1308447C
(zh)
*
|
2000-10-20 |
2007-04-04 |
中外制药株式会社 |
低分子化的激动剂抗体
|
WO2002096948A2
(en)
*
|
2001-01-29 |
2002-12-05 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
IL157142A0
(en)
*
|
2001-01-29 |
2004-02-08 |
Idec Pharma Corp |
Modified antibodies and methods of use
|
EP1409536A2
(de)
*
|
2001-02-12 |
2004-04-21 |
Curagen Corporation |
Menschliche proteine und dafür kodierende nukleinsäure
|
DE10156482A1
(de)
*
|
2001-11-12 |
2003-05-28 |
Gundram Jung |
Bispezifisches Antikörper-Molekül
|
JP2005518442A
(ja)
*
|
2001-11-20 |
2005-06-23 |
デューク・ユニバーシティー |
界面バイオマテリアル
|
EP1527346B1
(de)
|
2002-08-07 |
2011-06-08 |
Ablynx N.V. |
Modulation der blutplättchen-adhäsion basierend auf dem oberflächen-exponierten beta-switch loop des blutplättchen-glycoproteins ib-alpha
|
WO2004033499A1
(ja)
|
2002-10-11 |
2004-04-22 |
Chugai Seiyaku Kabushiki Kaisha |
細胞死誘導剤
|
US9701754B1
(en)
|
2002-10-23 |
2017-07-11 |
City Of Hope |
Covalent disulfide-linked diabodies and uses thereof
|
US9028816B2
(en)
|
2003-01-10 |
2015-05-12 |
Ablynx N.V. |
Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
|
JP2004279086A
(ja)
|
2003-03-13 |
2004-10-07 |
Konica Minolta Holdings Inc |
放射線画像変換パネル及び放射線画像変換パネルの製造方法
|
EP1609803A4
(de)
*
|
2003-03-31 |
2006-05-24 |
Chugai Pharmaceutical Co Ltd |
Modifizierter antikörper gegen cd22 und anwendungen dafür
|
US7888134B2
(en)
*
|
2003-06-05 |
2011-02-15 |
Oakland University |
Immunosensors: scFv-linker design for surface immobilization
|
US8597911B2
(en)
*
|
2003-06-11 |
2013-12-03 |
Chugai Seiyaku Kabushiki Kaisha |
Process for producing antibodies
|
WO2005000899A2
(en)
*
|
2003-06-27 |
2005-01-06 |
Biogen Idec Ma Inc. |
Modified binding molecules comprising connecting peptides
|
EP1660858A4
(de)
*
|
2003-07-21 |
2007-10-24 |
Amplified Proteomics Inc |
Multiplex-analytnachweis
|
US7696322B2
(en)
|
2003-07-28 |
2010-04-13 |
Catalent Pharma Solutions, Inc. |
Fusion antibodies
|
US8038983B2
(en)
*
|
2003-07-29 |
2011-10-18 |
Immunomedics, Inc. |
Fluorinated carbohydrate conjugates
|
WO2005056602A1
(ja)
*
|
2003-12-12 |
2005-06-23 |
Chugai Seiyaku Kabushiki Kaisha |
アゴニスト活性を有する改変抗体のスクリーニング方法
|
TW200530269A
(en)
|
2003-12-12 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Anti-Mpl antibodies
|
KR20060130606A
(ko)
*
|
2003-12-12 |
2006-12-19 |
추가이 세이야쿠 가부시키가이샤 |
세포사 유도제
|
US20050282233A1
(en)
*
|
2004-03-05 |
2005-12-22 |
Ludwig Institute For Cancer Research |
Multivalent antibody materials and methods for VEGF/PDGF family of growth factors
|
US20080274110A1
(en)
*
|
2004-04-09 |
2008-11-06 |
Shuji Ozaki |
Cell Death-Inducing Agents
|
US8470315B2
(en)
*
|
2004-04-13 |
2013-06-25 |
Quintessence Biosciences, Inc. |
Non-natural ribonuclease conjugates as cytotoxic agents
|
ES2342551T3
(es)
*
|
2004-06-16 |
2010-07-08 |
Affinergy Inc |
Biomateriales interfaciales (ifbm) para promover la adhesion especifica de substancias a analizar.
|
AU2005287375B8
(en)
*
|
2004-08-25 |
2009-11-12 |
The Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
WO2006074399A2
(en)
*
|
2005-01-05 |
2006-07-13 |
Biogen Idec Ma Inc. |
Multispecific binding molecules comprising connecting peptides
|
EP1836500B1
(de)
|
2005-01-14 |
2010-07-07 |
Ablynx N.V. |
Verfahren und testvorrichtungen zur unterscheidung verschiedener formen von krankheiten und leiden, die durch thrombocytopenia und/oder durch spontane interaktionen zwischen dem von-willebrand-faktor und plättchen gekennzeichnet sind
|
JP5057967B2
(ja)
|
2005-03-31 |
2012-10-24 |
中外製薬株式会社 |
sc(Fv)2構造異性体
|
JP5620626B2
(ja)
|
2005-03-31 |
2014-11-05 |
中外製薬株式会社 |
会合制御によるポリペプチド製造方法
|
US20090022687A1
(en)
*
|
2005-05-18 |
2009-01-22 |
Chugai Seiyaku Kabushiki Kaisha |
Novel Pharmaceuticals That Use Anti-HLA Antibodies
|
ES2694247T3
(es)
|
2005-05-20 |
2018-12-19 |
Ablynx N.V. |
NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
|
US20090028854A1
(en)
*
|
2005-06-10 |
2009-01-29 |
Chugai Seiyaku Kabushiki Kaisha |
sc(Fv)2 SITE-DIRECTED MUTANT
|
CN101237890A
(zh)
|
2005-06-10 |
2008-08-06 |
中外制药株式会社 |
含有葡甲胺的蛋白质制剂的稳定剂及其利用
|
KR101360671B1
(ko)
|
2005-06-10 |
2014-02-07 |
추가이 세이야쿠 가부시키가이샤 |
sc(Fv)2를 함유하는 의약조성물
|
US20070041934A1
(en)
*
|
2005-08-12 |
2007-02-22 |
Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
WO2007109321A2
(en)
*
|
2006-03-20 |
2007-09-27 |
The Regents Of The University Of California |
Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
|
JP5144499B2
(ja)
|
2006-03-31 |
2013-02-13 |
中外製薬株式会社 |
二重特異性抗体を精製するための抗体改変方法
|
WO2007145227A1
(ja)
*
|
2006-06-14 |
2007-12-21 |
Chugai Seiyaku Kabushiki Kaisha |
造血幹細胞増加促進剤
|
US8840882B2
(en)
*
|
2006-06-23 |
2014-09-23 |
Quintessence Biosciences, Inc. |
Modified ribonucleases
|
EP2048230A4
(de)
*
|
2006-07-13 |
2010-01-20 |
Chugai Pharmaceutical Co Ltd |
Zelltodinduzierer
|
EP2049151A4
(de)
|
2006-07-17 |
2010-03-24 |
Quintessence Biosciences Inc |
Verfahren und zusammensetzungen zur behandlung von krebs
|
CL2008000719A1
(es)
*
|
2007-03-12 |
2008-09-05 |
Univ Tokushima Chugai Seiyaku |
Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a
|
US20090088376A1
(en)
*
|
2007-04-19 |
2009-04-02 |
The Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
WO2008137120A1
(en)
*
|
2007-05-03 |
2008-11-13 |
Tethys Bioscience, Inc. |
Binding reagents that contain small epitope binding molecules
|
WO2008144827A1
(en)
|
2007-05-31 |
2008-12-04 |
The University Of Queensland |
Diagnostic markers for ankylosing spondylitis and uses thereof
|
US9175015B2
(en)
|
2007-08-22 |
2015-11-03 |
Colorado School Of Mines |
Gold nanoparticle conjugates and uses thereof
|
WO2009032949A2
(en)
|
2007-09-04 |
2009-03-12 |
The Regents Of The University Of California |
High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
|
WO2009046294A2
(en)
*
|
2007-10-03 |
2009-04-09 |
Cornell University |
Treatment of proliferative disorders using antibodies to psma
|
CA2702043A1
(en)
*
|
2007-10-08 |
2009-04-16 |
Quintessence Biosciences, Inc. |
Compositions and methods for ribonuclease-based therapies
|
US8075755B2
(en)
*
|
2007-12-13 |
2011-12-13 |
Bio-Rad Laboratories, Inc. |
Polymeric sorbent sheets as ion reservoirs for electroblotting
|
US8414893B2
(en)
|
2007-12-21 |
2013-04-09 |
Amgen Inc. |
Anti-amyloid antibodies and uses thereof
|
AU2009207645B2
(en)
|
2008-01-25 |
2014-11-13 |
Aarhus Universitet |
Selective exosite inhibition of PAPP-A activity against IGFBP-4
|
EP2574628B1
(de)
|
2008-01-25 |
2015-05-20 |
Amgen Inc. |
Ferroportin-Antikörper und Verwendungsverfahren
|
WO2009151687A2
(en)
|
2008-03-12 |
2009-12-17 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
MX2010011717A
(es)
|
2008-05-01 |
2010-11-30 |
Amgen Inc |
Anticuerpos anti-hepcidina y metodos de uso.
|
WO2009155932A2
(en)
|
2008-06-25 |
2009-12-30 |
H. Lundbeck A/S |
Modulation of the trpv : vps10p-domain receptor system for the treatment of pain
|
US20100069616A1
(en)
*
|
2008-08-06 |
2010-03-18 |
The Regents Of The University Of California |
Engineered antibody-nanoparticle conjugates
|
US8968705B2
(en)
|
2008-08-22 |
2015-03-03 |
Colorado School Of Mines |
Gold/lanthanide nanoparticle conjugates and uses thereof
|
US8790642B2
(en)
|
2008-08-29 |
2014-07-29 |
Genentech, Inc. |
Cross-reactive and bispecific anti-IL-17A/F antibodies
|
WO2010039861A2
(en)
|
2008-09-30 |
2010-04-08 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
US8029782B2
(en)
|
2008-10-01 |
2011-10-04 |
Quintessence Biosciences, Inc. |
Therapeutic ribonucleases
|
EP2352490A4
(de)
|
2008-10-09 |
2013-11-20 |
Univ Northeastern |
Selbstanordnende polymere multifunktionsnanosysteme
|
US9017644B2
(en)
|
2008-11-07 |
2015-04-28 |
The Regents Of The University Of Michigan |
Methods of treating autoimmune disorders and/or inflammatory disorders
|
US8703125B2
(en)
|
2008-12-19 |
2014-04-22 |
H. Lundbeck A/S |
Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
|
CA2752510C
(en)
*
|
2009-02-17 |
2024-01-23 |
Neil Bander |
Methods and kits for diagnosis of cancer and prediction of therapeutic value
|
JP2012521197A
(ja)
|
2009-03-20 |
2012-09-13 |
アムジエン・インコーポレーテツド |
担体免疫グロブリンおよびその使用
|
WO2010112034A2
(en)
|
2009-04-02 |
2010-10-07 |
Aarhus Universitet |
Compositions and methods for treatment and diagnosis of synucleinopathies
|
WO2011028952A1
(en)
|
2009-09-02 |
2011-03-10 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
US8945508B2
(en)
|
2009-10-13 |
2015-02-03 |
The Regents Of The University Of Michigan |
Dendrimer compositions and methods of synthesis
|
US8912323B2
(en)
|
2009-10-30 |
2014-12-16 |
The Regents Of The University Of Michigan |
Multifunctional small molecules
|
US9588121B2
(en)
|
2009-11-06 |
2017-03-07 |
Go Therapeutics, Inc. |
Method for early detection of cancer
|
AU2010321832B2
(en)
|
2009-11-20 |
2014-08-14 |
Amgen Inc. |
Anti-Orai1 antigen binding proteins and uses thereof
|
CA3040276A1
(en)
|
2009-12-02 |
2011-06-09 |
Imaginab, Inc. |
J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
|
US8715476B2
(en)
|
2009-12-11 |
2014-05-06 |
Bio-Rad Laboratories, Inc. |
Instrument for independent electrotransfer in multiple cassettes
|
US20110201076A1
(en)
|
2010-01-22 |
2011-08-18 |
Colorado School Of Mines |
Harvesting micro algae
|
WO2011147984A1
(en)
|
2010-05-28 |
2011-12-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
|
CN105585630B
(zh)
|
2010-07-29 |
2020-09-15 |
Xencor公司 |
具有修改的等电点的抗体
|
BR112013006679A2
(pt)
|
2010-09-22 |
2016-06-07 |
Amgen Inc |
imunoglobulinas carreadoras e seus usos
|
US10851178B2
(en)
|
2011-10-10 |
2020-12-01 |
Xencor, Inc. |
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
|
US9402911B2
(en)
|
2011-12-08 |
2016-08-02 |
The Regents Of The University Of Michigan |
Multifunctional small molecules
|
JP2015531751A
(ja)
*
|
2012-07-23 |
2015-11-05 |
ザイムワークス,インコーポレイテッド |
選択的対である軽鎖および重鎖を含む免疫グロブリン構築物
|
US9701759B2
(en)
|
2013-01-14 |
2017-07-11 |
Xencor, Inc. |
Heterodimeric proteins
|
US10487155B2
(en)
|
2013-01-14 |
2019-11-26 |
Xencor, Inc. |
Heterodimeric proteins
|
US10131710B2
(en)
|
2013-01-14 |
2018-11-20 |
Xencor, Inc. |
Optimized antibody variable regions
|
WO2014110601A1
(en)
|
2013-01-14 |
2014-07-17 |
Xencor, Inc. |
Novel heterodimeric proteins
|
US10968276B2
(en)
|
2013-03-12 |
2021-04-06 |
Xencor, Inc. |
Optimized anti-CD3 variable regions
|
US9605084B2
(en)
|
2013-03-15 |
2017-03-28 |
Xencor, Inc. |
Heterodimeric proteins
|
US11053316B2
(en)
|
2013-01-14 |
2021-07-06 |
Xencor, Inc. |
Optimized antibody variable regions
|
WO2014113510A1
(en)
|
2013-01-15 |
2014-07-24 |
Xencor, Inc. |
Rapid clearance of antigen complexes using novel antibodies
|
US10858417B2
(en)
|
2013-03-15 |
2020-12-08 |
Xencor, Inc. |
Heterodimeric proteins
|
US10519242B2
(en)
|
2013-03-15 |
2019-12-31 |
Xencor, Inc. |
Targeting regulatory T cells with heterodimeric proteins
|
US10106624B2
(en)
|
2013-03-15 |
2018-10-23 |
Xencor, Inc. |
Heterodimeric proteins
|
EP2970486B1
(de)
|
2013-03-15 |
2018-05-16 |
Xencor, Inc. |
Modulation von t-zellen mit bispezifischen antikörpern und fc-fusionen
|
AU2014300503B2
(en)
|
2013-06-28 |
2018-11-22 |
Auckland Uniservices Limited |
Amino acid and peptide conjugates and conjugation process
|
JP2016536326A
(ja)
|
2013-08-29 |
2016-11-24 |
ユニバーシティ オブ コペンハーゲン |
癌治療用抗adam12抗体
|
PT3050896T
(pt)
|
2013-09-27 |
2021-08-24 |
Chugai Pharmaceutical Co Ltd |
Processo para a produção de heteromultímeros de polipéptidos
|
PL3122781T3
(pl)
|
2014-03-28 |
2020-06-15 |
Xencor, Inc. |
Dwuswoiste przeciwciała, które wiążą się z CD38 i CD3
|
KR20170010863A
(ko)
|
2014-07-01 |
2017-02-01 |
화이자 인코포레이티드 |
이중특이성 이종이량체성 디아바디 및 이의 용도
|
BR112017011092A2
(pt)
|
2014-11-26 |
2017-12-26 |
Xencor Inc |
anticorpos heterodiméricos que ligam cd3 e antígenos de tumor
|
EA037065B1
(ru)
|
2014-11-26 |
2021-02-01 |
Ксенкор, Инк. |
Гетеродимерные антитела, связывающие cd3 и cd38
|
US10259887B2
(en)
|
2014-11-26 |
2019-04-16 |
Xencor, Inc. |
Heterodimeric antibodies that bind CD3 and tumor antigens
|
US10428155B2
(en)
|
2014-12-22 |
2019-10-01 |
Xencor, Inc. |
Trispecific antibodies
|
JP2018505152A
(ja)
|
2014-12-23 |
2018-02-22 |
アン ブリンブル マーガレット |
アミノ酸複合体及びペプチド複合体ならびにそれらの使用
|
WO2016141387A1
(en)
|
2015-03-05 |
2016-09-09 |
Xencor, Inc. |
Modulation of t cells with bispecific antibodies and fc fusions
|
EP3271402B1
(de)
|
2015-03-16 |
2021-04-28 |
Aarhus Universitet |
Antikörper gegen ein extrazelluläres region nbcn1
|
AU2016235662B2
(en)
|
2015-03-20 |
2020-07-30 |
Aarhus Universitet |
Inhibitors of PCSK9 for treatment of lipoprotein metabolism disorders
|
AU2016304764C1
(en)
|
2015-08-07 |
2023-06-01 |
Imaginab, Inc. |
Antigen binding constructs to target molecules
|
US11623957B2
(en)
|
2015-12-07 |
2023-04-11 |
Xencor, Inc. |
Heterodimeric antibodies that bind CD3 and PSMA
|
CA3004288A1
(en)
|
2015-12-28 |
2017-07-06 |
Nobuyuki Tanaka |
Method for promoting efficiency of purification of fc region-containing polypeptide
|
CA3014515A1
(en)
|
2016-02-26 |
2017-08-31 |
Auckland Uniservices Limited |
Amino acid and peptide conjugates and conjugation process
|
KR20230054508A
(ko)
|
2016-06-14 |
2023-04-24 |
젠코어 인코포레이티드 |
이중특이적 체크포인트 억제제 항체
|
KR20190020341A
(ko)
|
2016-06-28 |
2019-02-28 |
젠코어 인코포레이티드 |
소마토스타틴 수용체 2에 결합하는 이종이량체 항체
|
WO2018027147A1
(en)
*
|
2016-08-04 |
2018-02-08 |
H. Lee Moffitt Cancer Center And Research Institute Inc. |
Affinity maturated tag72 specific single chain antibodies
|
US10793632B2
(en)
|
2016-08-30 |
2020-10-06 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
DK3515455T3
(da)
|
2016-09-20 |
2021-07-05 |
Univ Aarhus |
Forbindelser til behandling af lidelser i lipoproteinmetabolismen
|
CN110214147A
(zh)
|
2016-10-14 |
2019-09-06 |
Xencor股份有限公司 |
IL15/IL15Rα异源二聚体FC-融合蛋白
|
WO2018141029A1
(en)
|
2017-02-06 |
2018-08-09 |
Meat & Livestock Australia Limited |
Immunostimulating compositions and uses therefore
|
US11266745B2
(en)
|
2017-02-08 |
2022-03-08 |
Imaginab, Inc. |
Extension sequences for diabodies
|
JP2020529832A
(ja)
|
2017-06-30 |
2020-10-15 |
ゼンコア インコーポレイテッド |
IL−15/IL−15Rαおよび抗原結合ドメインを含む標的化ヘテロダイマーFc融合タンパク質
|
JP2021502100A
(ja)
|
2017-11-08 |
2021-01-28 |
ゼンコア インコーポレイテッド |
新規抗pd−1配列を用いた二重特異性および単一特異性抗体
|
US10981992B2
(en)
|
2017-11-08 |
2021-04-20 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
US11319355B2
(en)
|
2017-12-19 |
2022-05-03 |
Xencor, Inc. |
Engineered IL-2 Fc fusion proteins
|
AU2019247415A1
(en)
|
2018-04-04 |
2020-10-22 |
Xencor, Inc. |
Heterodimeric antibodies that bind fibroblast activation protein
|
CA3097593A1
(en)
|
2018-04-18 |
2019-10-24 |
Xencor, Inc. |
Pd-1 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and pd-1 antigen binding domains and uses thereof
|
JP2021520829A
(ja)
|
2018-04-18 |
2021-08-26 |
ゼンコア インコーポレイテッド |
IL−15/IL−15RA Fc融合タンパク質およびTIM−3抗原結合ドメインを含む、TIM−3標的化ヘテロ二量体融合タンパク質
|
SG11202103192RA
(en)
|
2018-10-03 |
2021-04-29 |
Xencor Inc |
Il-12 heterodimeric fc-fusion proteins
|
KR20210134725A
(ko)
|
2019-03-01 |
2021-11-10 |
젠코어 인코포레이티드 |
Enpp3과 cd3에 결합하는 이종이량체 항체
|
WO2021231976A1
(en)
|
2020-05-14 |
2021-11-18 |
Xencor, Inc. |
Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
|
KR20230156079A
(ko)
|
2021-03-09 |
2023-11-13 |
젠코어 인코포레이티드 |
Cd3과 cldn6에 결합하는 이종이량체 항체
|
US11859012B2
(en)
|
2021-03-10 |
2024-01-02 |
Xencor, Inc. |
Heterodimeric antibodies that bind CD3 and GPC3
|
CN116925234B
(zh)
*
|
2022-04-02 |
2024-05-31 |
合肥星眸生物科技有限公司 |
一种编码抗vegf-a和ang-2双特异性抗体的aav载体
|